lipid x has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies
| Studies (lipid x) | Trials (lipid x) | Recent Studies (post-2010) (lipid x) | Studies (6-ketoprostaglandin f1 alpha) | Trials (6-ketoprostaglandin f1 alpha) | Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha) |
|---|---|---|---|---|---|
| 67 | 0 | 6 | 4,832 | 294 | 150 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callahan, KS; Harlan, JM; Maier, RV; Pohlman, TH; Winn, RK | 1 |
1 other study(ies) available for lipid x and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
A glycolipid precursor of bacterial lipopolysaccharide (lipid X) lacks activity against endothelial cells in vitro and is not toxic in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cattle; Cells, Cultured; Endothelium, Vascular; Escherichia coli; Glycolipids; Goats; Leukocyte Count; Limulus Test; Lipid A; Lipopolysaccharides; Radioimmunoassay; Vibrio cholerae | 1988 |